87 drugs reach their earliest generic-entry date in 2041

Jan 2041 · 2

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Erleada · 2 strengths apalutamide	apalutamide	Janssen Biotech	210951	14 Jan 2041	patent, carve-out possible
Phyrago · 6 strengths dasatinib	dasatinib	Handa Therap	216099	22 Jan 2041	patent

Feb 2041 · 10

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Rezenopy naloxone hydrochloride	naloxone hydrochloride	Scienture	215487	5 Feb 2041	patent
Ozempic · 3 strengths semaglutide	semaglutide	Novo	209637	17 Feb 2041	patent
Wegovy · 10 strengths semaglutide	semaglutide	Novo	215256	17 Feb 2041	patent
Wegovy Hd semaglutide	semaglutide	Novo	215256	17 Feb 2041	patent
Ycanth cantharidin	cantharidin	Verrica Pharms	212905	19 Feb 2041	patent
Wayrilz rilzabrutinib	rilzabrutinib	Genzyme Corp	219685	20 Feb 2041	patent
Hetlioz tasimelteon	tasimelteon	Vanda Pharms Inc	205677	21 Feb 2041	patent, carve-out possible
Hetlioz Lq tasimelteon	tasimelteon	Vanda Pharms Inc	214517	21 Feb 2041	patent, carve-out possible
Xywav calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	Jazz	212690	22 Feb 2041	patent, carve-out possible
Norliqva amlodipine besylate	amlodipine besylate	Cmp Dev Llc	214439	24 Feb 2041	patent

Mar 2041 · 2

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Norepinephrine Bitartrate In 5% Dextrose · 3 strengths norepinephrine bitartrate	norepinephrine bitartrate	Baxter Hlthcare Corp	214313	8 Mar 2041	patent
Kyzatrex · 2 strengths testosterone undecanoate	testosterone undecanoate	Marius	213953	29 Mar 2041	patent

Apr 2041 · 8

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Abilify Maintena Kit · 4 strengths aripiprazole	aripiprazole	Otsuka Pharm Co Ltd	202971	1 Apr 2041	patent, carve-out possible
Evrysdi risdiplam	risdiplam	Genentech Inc	213535	15 Apr 2041	patent
Evrysdi risdiplam	risdiplam	Genentech Inc	219285	15 Apr 2041	patent
Xofluza · 3 strengths baloxavir marboxil	baloxavir marboxil	Genentech Inc	214410	21 Apr 2041	patent
Dextenza dexamethasone	dexamethasone	Ocular Therapeutix	208742	26 Apr 2041	patent, carve-out possible
Tlando testosterone undecanoate	testosterone undecanoate	Verity	208088	28 Apr 2041	patent
Vyleesi (Autoinjector) bremelanotide acetate	bremelanotide acetate	Cosette	210557	29 Apr 2041	patent, carve-out possible
Cavhanza · 2 strengths nilotinib	nilotinib	Cycle	217379	30 Apr 2041	patent

May 2041 · 6

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Opzelura ruxolitinib phosphate	ruxolitinib phosphate	Incyte Corp	215309	5 May 2041	patent, carve-out possible
Zanvastro zilganersen sodium	zilganersen sodium	Ionis Pharms Inc	220210	20 May 2041	patent
Eliquis Sprinkle apixaban	apixaban	Bristol	220073	22 May 2041	patent
Epsolay benzoyl peroxide	benzoyl peroxide	Mayne Pharma	214510	23 May 2041	patent
Twyneo benzoyl peroxide; tretinoin	benzoyl peroxide; tretinoin	Mayne Pharma	214902	23 May 2041	patent
Oxlumo lumasiran sodium	lumasiran sodium	Alnylam Pharms Inc	214103	29 May 2041	patent

Jun 2041 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Austedo Xr · 8 strengths deutetrabenazine	deutetrabenazine	Teva	216354	10 Jun 2041	patent
Zimhi naloxone hydrochloride	naloxone hydrochloride	Zmi Pharma	212854	14 Jun 2041	patent
Femlyv ethinyl estradiol; norethindrone acetate	ethinyl estradiol; norethindrone acetate	Millicent Mfg Pr	218718	24 Jun 2041	patent

Jul 2041 · 13

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Multrys cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	Am Regent	209376	1 Jul 2041	patent
Selenious Acid · 3 strengths selenious acid	selenious acid	Am Regent	209379	1 Jul 2041	patent
Tralement · 2 strengths cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	Am Regent	209376	1 Jul 2041	patent
Advil Dual Action With Acetaminophen acetaminophen; ibuprofen	acetaminophen; ibuprofen	Haleon Us Holdings	211733	9 Jul 2041	patent
Fabhalta iptacopan hydrochloride	iptacopan hydrochloride	Novartis	218276	15 Jul 2041	patent, carve-out possible
Acthar Gel corticotropin	corticotropin	Mallinckrodt Ireland	008372	18 Jul 2041	patent, carve-out possible
Acthar Gel (Autoinjector) · 2 strengths corticotropin	corticotropin	Mallinckrodt Ireland	008372	18 Jul 2041	patent, carve-out possible
Hernexeos zongertinib	zongertinib	Boehringer Ingelheim	219042	21 Jul 2041	patent
Onyda Xr clonidine hydrochloride	clonidine hydrochloride	Tris Pharma Inc	217645	28 Jul 2041	patent
Juxtapid · 5 strengths lomitapide mesylate	lomitapide mesylate	Chiesi	203858	29 Jul 2041	patent, carve-out possible
Qulipta atogepant	atogepant	Abbvie	215206	29 Jul 2041	patent, carve-out possible
Aqvesme mitapivat sulfate	mitapivat sulfate	Agios Pharms Inc	216196	31 Jul 2041	patent, carve-out possible
Pyrukynd · 3 strengths mitapivat sulfate	mitapivat sulfate	Agios Pharms Inc	216196	31 Jul 2041	patent, carve-out possible

Aug 2041 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Lazcluze · 2 strengths lazertinib mesylate	lazertinib mesylate	Janssen Biotech	219008	1 Aug 2041	patent, carve-out possible
Qvar Redihaler · 2 strengths beclomethasone dipropionate	beclomethasone dipropionate	Norton Waterford	207921	19 Aug 2041	patent
Sunlenca lenacapavir sodium	lenacapavir sodium	Gilead Sciences Inc	215974	28 Aug 2041	patent, carve-out possible
Sunlenca lenacapavir sodium	lenacapavir sodium	Gilead Sciences Inc	215973	28 Aug 2041	patent, carve-out possible

Sep 2041 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Detectnet copper cu-64 dotatate	copper cu-64 dotatate	Curium	213227	3 Sep 2041	patent
Mavenclad cladribine	cladribine	Emd Serono Inc	022561	10 Sep 2041	patent, carve-out possible
Jaypirca · 2 strengths pirtobrutinib	pirtobrutinib	Loxo Oncol	216059	14 Sep 2041	patent
Pluvicto lutetium lu-177 vipivotide tetraxetan	lutetium lu-177 vipivotide tetraxetan	Novartis	215833	18 Sep 2041	patent, carve-out possible

Oct 2041 · 11

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Farxiga dapagliflozin	dapagliflozin	Astrazeneca Ab	202293	1 Oct 2041	patent
Brenzavvy bexagliflozin	bexagliflozin	Theracosbio	214373	5 Oct 2041	patent
Arbli losartan potassium	losartan potassium	Scienture	218772	7 Oct 2041	patent
Atzumi dihydroergotamine mesylate	dihydroergotamine mesylate	Satsuma Pharms	217901	12 Oct 2041	patent
Potassium Phosphates In 0.9% Sodium Chloride · 2 strengths potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	Fresenius Kabi Usa	212832	12 Oct 2041	patent
Potassium Phosphates In 0.9% Sodium Chloride potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	Amneal	218343	12 Oct 2041	patent
Litfulo ritlecitinib tosylate	ritlecitinib tosylate	Pfizer	215830	17 Oct 2041	patent
Etcamah camizestrant	camizestrant	Astrazeneca	220359	22 Oct 2041	patent
Lynparza · 2 strengths olaparib	olaparib	Astrazeneca	208558	25 Oct 2041	patent, carve-out possible
Kyprolis · 3 strengths carfilzomib	carfilzomib	Onyx Pharms Amgen	202714	29 Oct 2041	patent
Paxlovid (Copackaged) nirmatrelvir; ritonavir	nirmatrelvir; ritonavir	Pfizer	217188	31 Oct 2041	patent, carve-out possible

Nov 2041 · 8

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Bylvay · 4 strengths odevixibat	odevixibat	Ipsen	215498	12 Nov 2041	patent, carve-out possible
Lybalvi · 4 strengths olanzapine; samidorphan l-malate	olanzapine; samidorphan l-malate	Alkermes Inc	213378	12 Nov 2041	patent
Radicava Ors edaravone	edaravone	Shionogi	215446	12 Nov 2041	patent, carve-out possible
Icotyde icotrokinra hydrochloride	icotrokinra hydrochloride	Janssen Biotech	220149	19 Nov 2041	patent
Miplyffa · 4 strengths arimoclomol citrate	arimoclomol citrate	Zevra Denmark	214927	19 Nov 2041	patent
Invega Hafyera · 2 strengths paliperidone palmitate	paliperidone palmitate	Janssen Pharms	207946	24 Nov 2041	patent, carve-out possible
Posluma flotufolastat f-18 gallium	flotufolastat f-18 gallium	Blue Earth	216023	27 Nov 2041	patent
Veklury remdesivir	remdesivir	Gilead Sciences Inc	214787	28 Nov 2041	patent

Dec 2041 · 16

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Solosec secnidazole	secnidazole	Evofem Inc	209363	11 Dec 2041	patent, carve-out possible
Opipza · 3 strengths aripiprazole	aripiprazole	Xiamen Lp Pharm Co	216655	15 Dec 2041	patent
Crexont · 4 strengths carbidopa; levodopa	carbidopa; levodopa	Impax	217186	21 Dec 2041	patent, carve-out possible
Eligard Kit leuprolide acetate	leuprolide acetate	Tolmar	021379	22 Dec 2041	patent
Eligard Kit leuprolide acetate	leuprolide acetate	Tolmar	021343	22 Dec 2041	patent
Eligard Kit leuprolide acetate	leuprolide acetate	Tolmar	021731	22 Dec 2041	patent
Eligard Kit leuprolide acetate	leuprolide acetate	Tolmar	021488	22 Dec 2041	patent
Fensolvi Kit leuprolide acetate	leuprolide acetate	Tolmar	213150	22 Dec 2041	patent
Lifyorli (Copackaged) relacorilant	relacorilant	Corcept Therap	220641	22 Dec 2041	patent
Ubrelvy · 2 strengths ubrogepant	ubrogepant	Abbvie	211765	22 Dec 2041	patent, carve-out possible
Xromi hydroxyurea	hydroxyurea	Nova Labs Ltd	216593	23 Dec 2041	patent
Aphexda motixafortide acetate	motixafortide acetate	Ayrmid Pharma	217159	29 Dec 2041	patent
Bynfezia Pen octreotide acetate	octreotide acetate	Sun Pharm	213224	29 Dec 2041	patent, carve-out possible
Mounjaro · 12 strengths tirzepatide	tirzepatide	Eli Lilly And Co	215866	30 Dec 2041	patent, carve-out possible
Mounjaro (Autoinjector) · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	215866	30 Dec 2041	patent, carve-out possible
Mounjaro Kwikpen · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	215866	30 Dec 2041	patent, carve-out possible